跳至主要内容
临床试验/ITMCTR1900002668
ITMCTR1900002668招募中未知

Clinical Study for Qingfei Huatan Granule to Reduce the Course of Acute Exacerbation of COPD

The First Affiliated Hospital of Anhui University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 80(—)
性别
All

入选标准

  • 1. A confirmed diagnosis of AECOPD;
  • 2. Syndrome of phlegm-heat obstructing lung;
  • 3. Aged between 40 and 80 years;
  • 4. Voluntary treatment, with the informed consent signed.

排除标准

  • 1. Pregnant or breast-feeding women;
  • 2. Complicated with cardio-cerebrovascular diseases (malignant arrhythmia, unstable hemodynamics, acute myocardial infarction, NYHA Class III or IV,cerebral apoplexy, cerebral hemorrhage, etc);
  • 3. Complicated with bronchiectasis, bronchial asthma, tuberculosis, bronchiolitis obliterans, diffuse panbronchiolitis, pulmonary embolism pneumothorax and pleural effusion, etc;
  • 4. Complicated with respiratory failure, need endotracheal intubation and ventilator breathing to assist breathing;
  • 5. Complicated with serious liver and renal diseases(Serious liver disease refers to cirrhosis, portal hypertension and varices bleeding,severe kidney disease, including dialysis, kidney transplantation);
  • 6. Combination of tumor or neuromuscular disease affecting the respiratory movement function;
  • 7. Long-term bedridden patients;
  • 8. Congenital or acquired immunodeficiency;
  • 9. Delirious, dementia, and all kinds of psychiatric patients;
  • 10. Patients with oral corticosteroids within 1 mounth before enrollment;
  • 11. Participating in other trials within 1 mounth before enrollment or allergic to the used medicine.

研究者

发起方
The First Affiliated Hospital of Anhui University of Chinese Medicine

相似试验